For the latest onThailand Medical Industry, Thailand Doctors, Thailand Medical Research, Thailand Hospitals, Thailand Wellness Initiatives and the latest Medical News

BREAKING NEWS
Source: COVID-19 Drugs  Jul 09, 2020  5 years, 7 months, 6 days, 19 hours, 12 minutes ago

COVID-19 Drugs: Coronavir, A New Antiviral To Treat COVID-19 Approved For Use By Regulatory Agency in Russia

COVID-19 Drugs: Coronavir, A New Antiviral To Treat COVID-19 Approved For Use By Regulatory Agency in Russia
Source: COVID-19 Drugs  Jul 09, 2020  5 years, 7 months, 6 days, 19 hours, 12 minutes ago
COVID-19 Drugs: R-Pharm, a Russian pharmaceutical company has secured regulatory approval for the use of its antiviral drug Coronavir, to treat patients suffering from Covid-19. The company released the announcement today to Russian media.


 
The regulatory approval comes after a clinical trial in mild to moderate Covid-19 patients showed that the drug is highly effective in blocking replication of SARS-CoV-2, the novel coronavirus that causes the disease.
 
The Russian biotech and pharma company told media, “Coronavir is one of the first drugs in Russia and in the world that does not tackle the complications caused by SARS-CoV-2, but battles the virus itself.”
 
Clinical study data revealed improvement in 55% of outpatients on day seven of treatment with the drug, compared to 20% of those on standard etiotropic therapy, which targets disease cause instead of symptoms.
 
Furthermore a significant difference was observed at 14 days, added the company. The virus was found to be eliminated in 77.5% of Covid-19 patients by day five of treatment with Coronavir.
 
R-Pharm medical director Dr Mikhail Samsonov told Thailand Medical News via  a phone interview a few hours ago, “Global clinical practice and the clinical study we conducted have confirmed that Coronavir puts a much more rapid stop to the infection as a result of its effective obstruction of the virus’s replication.”
 
Russia’s Central Research Institute of Epidemiology clinical trials head Tatyana Ryzhentsova, the drug entered clinical testing in May and has been used to treat more than 110 outpatients so far.
 
However when asked the constituents or the drug and the way it works and also which journals the studies are published in, there was no answer from the agency nor the company.
 
Thailand Medical News will giving updates on this as more details emerge. In the meantime, for more articles on COVID-19 Drugs, keep on logging to Thailand Medical News.

MOST READ

Feb 12, 2026  4 days ago
Nikhil Prasad
Feb 11, 2026  5 days ago
Nikhil Prasad
Feb 09, 2026  7 days ago
Nikhil Prasad
Feb 08, 2026  8 days ago
Nikhil Prasad
Feb 08, 2026  8 days ago
Nikhil Prasad
Feb 06, 2026  10 days ago
Nikhil Prasad
Feb 04, 2026  12 days ago
Nikhil Prasad
Feb 02, 2026  14 days ago
Nikhil Prasad
Feb 01, 2026  15 days ago
Nikhil Prasad
Jan 31, 2026  16 days ago
Nikhil Prasad
Jan 27, 2026  20 days ago
Nikhil Prasad
Jan 27, 2026  20 days ago
Nikhil Prasad
Jan 26, 2026  21 days ago
Nikhil Prasad
Jan 25, 2026  22 days ago
Nikhil Prasad
Jan 24, 2026  23 days ago
Nikhil Prasad
Jan 23, 2026  24 days ago
Nikhil Prasad
Jan 22, 2026  25 days ago
Nikhil Prasad
Jan 21, 2026  26 days ago
Nikhil Prasad